Taro Pharmaceutical Industries Stock Market Value
| TARO Stock | USD 42.19 0.05 0.12% |
| Symbol | Taro |
Taro Pharmaceutical Price To Book Ratio
Is Taro Pharmaceutical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Taro Pharmaceutical. If investors know Taro will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Taro Pharmaceutical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 1.782 | Earnings Share 1.22 | Revenue Per Share 16.252 | Quarterly Revenue Growth 0.129 | Return On Assets 0.0103 |
The market value of Taro Pharmaceutical is measured differently than its book value, which is the value of Taro that is recorded on the company's balance sheet. Investors also form their own opinion of Taro Pharmaceutical's value that differs from its market value or its book value, called intrinsic value, which is Taro Pharmaceutical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Taro Pharmaceutical's market value can be influenced by many factors that don't directly affect Taro Pharmaceutical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Taro Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Taro Pharmaceutical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Taro Pharmaceutical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Taro Pharmaceutical 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Taro Pharmaceutical's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Taro Pharmaceutical.
| 03/20/2024 |
| 04/19/2024 |
If you would invest 0.00 in Taro Pharmaceutical on March 20, 2024 and sell it all today you would earn a total of 0.00 from holding Taro Pharmaceutical Industries or generate 0.0% return on investment in Taro Pharmaceutical over 30 days. Taro Pharmaceutical is related to or competes with Alkermes Plc, Ironwood Pharmaceuticals, Deciphera Pharmaceuticals, Eagle Pharmaceuticals, Neurocrine Biosciences, and Dynavax Technologies. Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescri... More
Taro Pharmaceutical Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Taro Pharmaceutical's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Taro Pharmaceutical Industries upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 0.5476 | |||
| Information Ratio | (0.03) | |||
| Maximum Drawdown | 5.18 | |||
| Value At Risk | (0.47) | |||
| Potential Upside | 1.22 |
Taro Pharmaceutical Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Taro Pharmaceutical's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Taro Pharmaceutical's standard deviation. In reality, there are many statistical measures that can use Taro Pharmaceutical historical prices to predict the future Taro Pharmaceutical's volatility.| Risk Adjusted Performance | 0.0392 | |||
| Jensen Alpha | 0.0206 | |||
| Total Risk Alpha | (0.03) | |||
| Sortino Ratio | (0.04) | |||
| Treynor Ratio | 0.1458 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Taro Pharmaceutical's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Taro Pharmaceutical Backtested Returns
Taro Pharmaceutical owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.001, which indicates the firm had a -0.001% return per unit of risk over the last 3 months. Taro Pharmaceutical Industries exposes twenty-nine different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Taro Pharmaceutical's Coefficient Of Variation of 1643.61, semi deviation of 0.4575, and Risk Adjusted Performance of 0.0392 to confirm the risk estimate we provide. The entity has a beta of 0.24, which indicates not very significant fluctuations relative to the market. As returns on the market increase, Taro Pharmaceutical's returns are expected to increase less than the market. However, during the bear market, the loss of holding Taro Pharmaceutical is expected to be smaller as well. Taro Pharmaceutical has an expected return of -7.0E-4%. Please make sure to validate Taro Pharmaceutical potential upside, as well as the relationship between the kurtosis and day typical price , to decide if Taro Pharmaceutical performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.33 |
Below average predictability
Taro Pharmaceutical Industries has below average predictability. Overlapping area represents the amount of predictability between Taro Pharmaceutical time series from 20th of March 2024 to 4th of April 2024 and 4th of April 2024 to 19th of April 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Taro Pharmaceutical price movement. The serial correlation of 0.33 indicates that nearly 33.0% of current Taro Pharmaceutical price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.33 | |
| Spearman Rank Test | -0.28 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Taro Pharmaceutical lagged returns against current returns
Autocorrelation, which is Taro Pharmaceutical stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Taro Pharmaceutical's stock expected returns. We can calculate the autocorrelation of Taro Pharmaceutical returns to help us make a trade decision. For example, suppose you find that Taro Pharmaceutical has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Taro Pharmaceutical regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Taro Pharmaceutical stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Taro Pharmaceutical stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Taro Pharmaceutical stock over time.
Current vs Lagged Prices |
| Timeline |
Taro Pharmaceutical Lagged Returns
When evaluating Taro Pharmaceutical's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Taro Pharmaceutical stock have on its future price. Taro Pharmaceutical autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Taro Pharmaceutical autocorrelation shows the relationship between Taro Pharmaceutical stock current value and its past values and can show if there is a momentum factor associated with investing in Taro Pharmaceutical Industries.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
When determining whether Taro Pharmaceutical offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Taro Pharmaceutical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Taro Pharmaceutical Industries Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Taro Pharmaceutical Industries Stock:Check out Taro Pharmaceutical Correlation, Taro Pharmaceutical Volatility and Taro Pharmaceutical Alpha and Beta module to complement your research on Taro Pharmaceutical. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Complementary Tools for Taro Stock analysis
When running Taro Pharmaceutical's price analysis, check to measure Taro Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Taro Pharmaceutical is operating at the current time. Most of Taro Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Taro Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Taro Pharmaceutical's price. Additionally, you may evaluate how the addition of Taro Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Stocks Directory Find actively traded stocks across global markets | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |
Taro Pharmaceutical technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.